(123) 456-7890
123 Somewhere Drive

Our Products

MOLD Phase 2 Symptom Relief

Finally - a Mold Protocol That Supports the Body, Mind, and Immune System in One Complete Kit.

  • Complete protocol supporting the body's response to three key mold species (Aspergillus, Penicillium, and Stachybotrys) with both organism and DNA energetic signatures.
  • Flexible system that supports immune resilience, emotional terrain, and inflammatory balance in one integrated kit suitable for even highly sensitive individuals.
  • Supports cognitive clarity and emotional balance in individuals experiencing mold-related brain fog, especially relevant with mold found in 70% of US homes.

In Stock

Save

Prevalence and Impact of Mold Exposure

Understanding how pervasive mold exposure affects your patients' health is crucial for comprehensive treatment. The prevalence is staggering:

  • 70% of homes in the U.S. have some form of mold present[1]
  • Over 45 million buildings across the U.S. have unhealthy levels of mold[2]
  • 21% of current asthma cases in the U.S. are attributable to dampness and mold exposure[4]
  • Damp or moldy environments increase respiratory issues risk by 30–50%[10]
  • Over 75,000 people are hospitalized annually for fungal infections, with at least 7,000 deaths[8]

→ Mold exposure is one of the most overlooked environmental factors impacting your patients' respiratory and systemic health.

What's Inside the Mold Phase 2 Kit?

Mold 1M

Mold:1M

▼

Homeopathic Indications: For the temporary relief of symptoms including cough, fever, fatigue, and nausea.

Three Targeted Species + DNA at 1M Potency:
  • Aspergillus niger (1M) + DNA (1M)
  • Penicillium verrucosum (1M) + DNA (1M)
  • Stachybotrys chartarum (1M) + DNA (1M)
Phase 2 Progression: The 1M potency represents a significant step up from Phase 1's graduated potencies, working at a deeper energetic level to continue supporting the body's adaptation and healing process.
Mold 10M

Mold:10M

▼

Homeopathic Indications: For the temporary relief of symptoms including cough, fever, fatigue, and nausea.

Three Targeted Species + DNA at 10M Potency:
  • Aspergillus niger (10M) + DNA (10M)
  • Penicillium verrucosum (10M) + DNA (10M)
  • Stachybotrys chartarum (10M) + DNA (10M)
Maximum Potency Support: The 10M potency provides the highest level of energetic information for a deeper support of the body's adaptation and healing process..
Mold Plus

Mold Plus (2)

▼

Homeopathic Indications: A 20-ingredient homeopathic formula that provides broad-spectrum mold and terrain support. Continued use in Phase 2 maintains comprehensive coverage while the high-potency remedies work at deeper levels.

Phase 2 Benefits:
  • Continues broad-spectrum mold species coverage
  • Maintains terrain support during deeper healing
  • Helps address lingering co-exposures and sensitivities
  • Provides stability while working with higher potencies
PTS Stress Remedy

PTS/Stress Remedy

▼

Homeopathic Indications: For the temporary relief of symptoms of stress including terror, horror, stress, fight or flight, nightmares, difficulty sleeping, easy irritability, difficulty concentrating, and restlessness.

Why PTS/Stress in Phase 2:
  • Addresses deeper trauma patterns that surface during advanced healing
  • Supports nervous system regulation as the body releases stored toxins
  • Supports the emotional processing that occurs with high-potency remedies
  • Assists the body in reducing fight-or-flight responses that can intensify during detoxification

Many patients experience stored trauma release during Phase 2, making this emotional support essential for protocol completion.

Liposomal Resveratrol Curcumin

Liposomal Resveratrol Curcumin

▼

Description: Continued antioxidant and anti-inflammatory support remains crucial in Phase 2 as the body works with higher potencies and deeper healing processes.

Phase 2 Support:
  • Maintains anti-inflammatory pathways during intensified healing
  • Continues mycotoxin neutralization support
  • Protects cellular integrity during deeper detoxification
  • Supports mitochondrial recovery and energy production
Smart Silver

Smart Silver 8oz (2)

▼

Description: Continued immune support through Phase 2 helps maintain resilience as the body addresses deeper layers of mold-related challenges.

Phase 2 Benefits:
  • Maintains immune vigilance during advanced protocols
  • Supports microbial balance as toxins are released
  • Helps prevent opportunistic infections during healing crises
  • Provides consistent antimicrobial support throughout the journey

Two 8oz bottles ensure adequate supply for the complete Phase 2 protocol duration.

The Hidden Impacts of Mold Exposure

Understanding how mold affects multiple body systems reveals why comprehensive support is essential for recovery:

Woman looking concerned - cognitive impact

Cognitive Impairment & Brain Inflammation

Inhaling mold triggers immune activation that spreads inflammatory responses to the brain, causing "brain fog," memory lapses, and difficulty concentrating.

Woman exercising - inflammation impact

Chronic Inflammation & Neuroimmune Disruption

Even non-toxic mold components activate immune pathways, causing prolonged inflammation affecting cognitive and emotional function.

Two friends, one consoling - emotional impact

Neurological & Psychiatric Symptoms

Mold exposure may contribute to emotional disorders and alter neurochemistry, including dopamine release, compounding brain-related symptoms over time.

Bathroom with hidden mold - respiratory burden

Respiratory & Immune System Burden

Firmly linked to wheezing, congestion, sinusitis, and hypersensitivity pneumonitis, creating chronic immune activation and heightened allergy risk.

Exhausted man - sick building syndrome

"Sick Building Syndrome" Effect

Occupants in moldy buildings experience headaches, fatigue, eye/nasal irritation, and general malaise—collectively known as Sick Building Syndrome.

Woman and moldy shower - diagnostic challenges

Diagnostic & Testing Challenges

Self-reported symptoms and unvalidated tests create risk for misdiagnosis, while methodological flaws cloud understanding of mold's true impact.

Mold exposure creates a complex web of symptoms affecting your entire body—addressing it requires comprehensive support for both detoxification and system support.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary with dietary supplements and homeopathic remedies. For homeopathic products, statements are based upon traditional homeopathic practices.

MOLD Phase 2 Symptom Relief

Finally - a Mold Protocol That Supports the Body, Mind, and Immune System in One Complete Kit.

  • Complete protocol supporting the body's response to three key mold species (Aspergillus, Penicillium, and Stachybotrys) with both organism and DNA energetic signatures.
  • Flexible system that supports immune resilience, emotional terrain, and inflammatory balance in one integrated kit suitable for even highly sensitive individuals.
  • Supports cognitive clarity and emotional balance in individuals experiencing mold-related brain fog, especially relevant with mold found in 70% of US homes.

In Stock

Save

References

Supporting Research on Mold Exposure and Health Impacts

1. Harding CF, Pytte CL, Page KG, et al. (2019). Mold inhalation causes innate immune activation, neural, cognitive and emotional dysfunction. Brain, Behavior, and Immunity. Demonstrated that controlled inhalation of both toxic and non-toxic mold can activate immune responses in the brain and alter cognitive behavior.
2. Harding CF, Liao D, Persaud R, et al. (2023). Repeated mold exposure causes progressive cognitive deficits via cerebellar-dependent mechanisms. Neurobiology of Disease. In animal models, exposure to mold spores—regardless of toxicity—impaired long-term memory, confirmed through performance changes in the Morris water maze.
3. Caillaud D, Leynaert B, Keirsbulck M, et al. (2018). Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies. European Respiratory Review. Reviewed evidence linking indoor mold exposure to increased rates of asthma and allergic rhinitis.
4. Cox-Ganser JM, Rao CY, Park JH, et al. (2015). Quantifying mold exposure: Environmental and personal monitoring analysis. Journal of Occupational and Environmental Medicine. Meta-analysis estimating that 21% of U.S. asthma cases (≈4.6 million) can be attributed to dampness and mold exposure; risk of asthma increases by 30–50% in moldy environments.
5. Ehsanifar M. (2023). Cognitive impairment and brain MRI changes due to mold exposure: A single-center cross-sectional study. Clinical Neurology and Neuroscience. Documented cognitive impairments—including visuospatial memory, learning, verbal function, and psychomotor speed—in patients with mold exposure.
6. Ratnaseelan AM, Tsilioni I, Theoharides TC. (2018). Effects of mycotoxins on neuropsychiatric symptoms and immune processes. Clinical Therapeutics. Identified mechanisms by which mycotoxins and mold exposure may contribute to neurodevelopmental and neuropsychiatric disorders.
7. Groot J, Cobzaru R, Lipman T. (2023). The health effects of residential damp and mould exposure: A systematic review. Indoor and Built Environment. Systematic review reinforcing that residential exposure to mold and dampness predisposes individuals—especially children—to respiratory illnesses like asthma.
8. Clark N, Ammann HM, Brunekreef B, et al. (2023). Damp housing and respiratory health: Quantifying the public health burden in England. International Journal of Environmental Research and Public Health. Estimated that damp and mold exposure in housing is linked to approximately 5,000 new asthma cases and 8,500 cases of lower respiratory infections annually in England.
9. World Health Organization. (2023). WHO guidelines for indoor air quality: Dampness and mould. WHO Technical Report. Highlights that prolonged exposure to mold and damp environments is correlated with respiratory symptoms, infections, allergic reactions, and elevated asthma risk—particularly in infants and immunocompromised populations.
10. Institute of Medicine. (2022). Damp indoor spaces and health: Sick building syndrome review. National Academies Press. Notes that damp indoor environments and mold raise asthma risk by 30–50% and are implicated in broader non-specific symptoms including fatigue and headaches.

Separate Checkout for Pre-Orders

This pre-order product must be purchased separately. We will redirect you to the checkout to complete this order.

Don't worry, we've saved your current cart and will restore it automatically after your purchase.

    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping